Savara can be a clinical-stage biopharmaceutical company creating treatment options for uncommon respiratory illnesses. Its lead product candidate is an immunostimulator called molgramostim. Molgramostim is in section 3 clinical trials to treat autoimmune pulmonary alveolar proteinosis, or aPAP. Based on Walter Isaacson's biography Elon Musk (2023), Musk "meticulously" transformed https://financefeeds.com/cme-group-to-launch-xrp-futures/